No definition available.
Endpoint definition
↥Report an error or suggest an improvement for this endpoint codes
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
519870 |
1. Apply sex-specific ruleNone |
519870 |
2. Check conditionsNone |
519870 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters: 2 out of 7 registries used, show all original rules. |
255 |
4. Check minimum number of eventsNone |
255 |
5. Include endpointsNone |
255 |
6. Filter based on genotype QC (FinnGen only) |
248 |
Control definitions (FinnGen only)
Controls for this endpoint are individuals that are not cases.
Similar endpoints
↥List of similar endpoints to
Cystic disease of liver
based on the number of shared cases.
Similar with more cases:
- Congenital malformations of gallbladder, bile ducts and liver
- Other congenital malformations of the digestive system
- Other congenital malformations of the digestive system, including avohilmo
- Congenital malformations, deformations and chromosomal abnormalities
- Congenital malformations, deformations and chromosomal abnormalities, including avohilmo
Similar with less cases:
None
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
This endpoint is excluded (different definition than used in FinnGen).
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 248 | 178 | 70 |
| Unadjusted period prevalence (%) | 0.05 | 0.06 | 0.03 |
| Median age at first event (years) | 57.23 | 55.23 | 62.30 |
-FinnGen-
Age distribution of first events
-FinnGen-
Year distribution of first events
-FinnGen-
Cumulative Incidence Function
No data
CodeWAS
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 255
- Matched controls
- 2550
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
Q44.6
ICD-10 Finland
Cystic disease of liver
+∞
307.7
255
*
K76.80
ICD-10 Finland
Hepatic cyst
295.2
110.2
105
6
127
Kela drug reimbursment
Transplant complication
43.0
74.6
46
13
Q61.2
ICD-10 Finland
Polycystic kidney, autosomal dominant
863.0
69.5
65
*
Q61.3
ICD-10 Finland
Polycystic kidney, unspecified
248.8
58.7
58
*
L04AA06
ATC
mycophenolic acid; systemic
26.3
58.2
42
19
138
Kela drug reimbursment
Severe anaemia associated with chronic renal failure
25.4
53.5
39
18
JN3AE
NOMESCO Finland
Abdominal ultrasound examination
7.5
51.3
98
196
123
Kela drug reimbursment
Chronic disorders of vitamin D metabolism
18.3
41.7
35
22
JN1AE
NOMESCO Finland
Ultrasound examination of upper part of abdomen
7.0
40.1
74
140
JJ5KT
NOMESCO Finland
Sclerotherapy of liver cyst
+∞
36.3
34
*
JN3AD
NOMESCO Finland
Abdominal CT examination
5.8
35.8
85
203
JJA31
NOMESCO Finland
Laparoscopic marsupialisation of cyst of liver
+∞
35.2
33
*
A11CC03
ATC
alfacalcidol; systemic
15.1
34.6
32
24
Z94.0
ICD-10 Finland
Kidney transplant status
80.6
31.8
35
5
TPH15
NOMESCO Finland
Insertion of central venous catheter through external or internal jugular vein
7.6
28.3
44
68
L04AD02
ATC
tacrolimus; systemic
60.6
27.9
32
6
JN3BD
NOMESCO Finland
Extensive abdominal CT
5.4
27.1
64
149
Z94.4
ICD-10 Finland
Liver transplant status
78.1
25.4
28
*
TK800
NOMESCO Finland
Hemodialysis
23.1
25.2
36
18
R10.4
ICD-10 Finland
Other and unspecified abdominal pain
3.7
23.7
149
700
KAS10
NOMESCO Finland
Allogenic transplantation of kidney from cadaver donor
72.0
23.3
26
*
JJC00
NOMESCO Finland
Allogenic transplantation of liver
92.1
23.1
25
*
PBL10
NOMESCO Finland
Construction of arteriovenous fistula from radial artery
39.1
22.6
28
8
Z49.1
ICD-10 Finland
Extracorporeal dialysis
39.4
20.2
25
7
I15.1
ICD-10 Finland
Hypertension secondary to other renal disorders
30.6
19.1
25
9
UJD10
NOMESCO Finland
Esophagoscopy, gastroscopy and duodenoscopy
3.3
19.0
119
540
J01EE01
ATC
sulfamethoxazole and trimethoprim; systemic
5.7
18.2
37
74
KA2AT
NOMESCO Finland
Biopsy of transplanted kidney with ultrasound guidance
102.3
17.8
19
*
JJ1AT
NOMESCO Finland
Puncture of lesion of liver with ultrasound guidance
192.8
17.7
18
*
JJ9AE
NOMESCO Finland
Ultrasound examination of liver transplant
192.8
17.7
18
*
N18.9
ICD-10 Finland
Chronic kidney disease, unspecified
5.5
17.7
37
76
JN1CG
NOMESCO Finland
Extensive MRI examination of upper part of abdomen with high intensity magnet
14.0
17.7
30
24
190
Kela drug reimbursment
Lanthanum carbonate, sevelamer and sucroferric oxyhydroxide
34.2
17.3
22
7
KA2AE
NOMESCO Finland
Ultrasound examination transplanted kidney
68.1
17.0
19
*
KA9AE
NOMESCO Finland
Ultrasound examination transplanted kidney
181.4
16.7
17
*
H02AB04
ATC
methylprednisolone; systemic
3.5
15.4
65
228
GD1AA
NOMESCO Finland
Thorax X-ray examination
2.9
15.1
162
954
B03XA02
ATC
darbepoetin alfa; parenteral
14.4
15.1
25
19
Z49.0
ICD-10 Finland
Preparatory care for dialysis
34.0
15.0
19
6
A12AA04
ATC
calcium carbonate; oral
18.4
14.6
22
13
N10
ICD-10 Finland
Acute tubulo-interstitial nephritis
3.6
14.1
55
182
V03AE02
ATC
sevelamer; oral
56.6
14.0
16
*
PG1DE
NOMESCO Finland
Other extensive ultrasound examination of artery
5.1
13.7
31
68
N18.8
ICD-10 Finland
Other chronic renal failure
13.3
12.9
22
18
7531A
ICD-9 Finland
Congenital anomalies of urinary system, Cystic kidney disease
+∞
12.6
12
*
L04AD01
ATC
ciclosporin; systemic
11.9
12.3
22
20
205
Kela drug reimbursment
Chronic hypertension
2.7
12.3
91
433
JN1DG
NOMESCO Finland
Very extensive MRI examination of upper part of abdomen with high intensity magnet
10.1
12.3
24
26
A41.5
ICD-10 Finland
Sepsis due to other Gram-negative organisms
6.1
12.2
22
39
R10.1
ICD-10 Finland
Pain localized to upper abdomen
2.8
12.0
79
353
JJ5AT, ,
NOMESCO Finland
125.4
11.5
12
*
WX402
NOMESCO Finland
General anaesthesia
2.7
11.4
84
396
N18.0
ICD-10 Finland
End-stage renal disease
36.9
11.4
14
*
N02AX02
ATC
tramadol; systemic, rectal
2.5
11.3
140
843
UJF30
NOMESCO Finland
Ileoscopy through colon
3.4
11.1
46
157
C03CA01
ATC
furosemide; systemic
2.5
10.7
101
535
C08CA02
ATC
felodipine; oral
3.7
10.6
37
113
Q61.99
ICD-10 Finland
Cystic kidney disease, unspecified
+∞
10.5
10
*
JA3AT
NOMESCO Finland
Cathetrisation of abdominal cavity with ultrasound guidance
15.4
10.1
16
11
JN3DE
NOMESCO Finland
Abdominal extensive ultrasoudn examination with blood flow measurements after transplantation
41.8
10.1
12
*
JN3CD
NOMESCO Finland
Abdominal CT examination both without and with contrast
7.9
9.9
22
30
V03AE01
ATC
polystyrene sulfonate; oral
21.1
9.9
14
7
J01MA02
ATC
ciprofloxacin; systemic
2.3
9.6
119
702
KAC00
NOMESCO Finland
Nephrectomy
103.7
9.5
10
*
320
Kela drug reimbursment
Lanthanum carbonate, sevelamer and sucroferric oxyhydroxide
22.7
9.4
13
6
N18.5
ICD-10 Finland
Chronic kidney disease, stage 5
22.7
9.4
13
6
Q61.1
ICD-10 Finland
Polycystic kidney, autosomal recessive
+∞
9.4
9
*
K42.9
ICD-10 Finland
Umbilical hernia without obstruction or gangrene
4.3
9.0
24
60
B03XA03
ATC
methoxy polyethylene glycol-epoetin beta; parenteral
25.1
9.0
12
5
V03AE03
ATC
lanthanum carbonate; oral
28.6
8.6
11
*
KA1AE
NOMESCO Finland
Kidney ultrasound examination
8.3
8.5
18
23
7516D
ICD-9 Finland
Other congenital anomalies of digestive system, Anomalies of gallbladder, bile ducts and liver[HEPAR POLYCYSTICUM]
+∞
8.4
8
*
R50.9
ICD-10 Finland
Fever, unspecified
2.6
8.2
53
231
TPH07
NOMESCO Finland
Cathetrisation of artery
2.9
8.2
43
168
KBV00
NOMESCO Finland
Insertion of stent into ureter
34.5
8.1
10
*
ZXE50
NOMESCO Finland
More than nine and less than 12 hours
11.3
7.9
14
13
PBL09
NOMESCO Finland
Construction of arteriovenous fistula from brachial artery
46.4
7.8
9
*
C02AC05
ATC
moxonidine; oral
4.3
7.7
20
49
R4110
NOMESCO Finland
Physiotherapy
2.2
7.5
91
521
PG5RT
NOMESCO Finland
PTA of arterio-venous shunt for dialysis
82.4
7.5
8
*
A49.9
ICD-10 Finland
Bacterial infection, unspecified
2.8
7.4
39
152
JAF30
NOMESCO Finland
Repair of umbilical hernia using prosthetic material
11.3
7.4
13
12
Q61.0
ICD-10 Finland
Congenital single renal cyst
+∞
7.3
7
*
JJA30
NOMESCO Finland
Marsupialisation of cyst of liver
+∞
7.3
7
*
WZC10
NOMESCO Finland
Written specialist consultation based on a referral from a dentist or a physician
4.2
7.3
20
51
WX408
NOMESCO Finland
General anesthesy, balanced
2.2
7.3
84
471
3AC01, ,
NOMESCO Finland
16.3
7.3
11
7
Z2446
NOMESCO Finland
Social worker
3.5
7.2
26
81
C07AG02
ATC
carvedilol; oral
3.5
7.2
26
81
UJF32
NOMESCO Finland
Coloscopy
2.1
7.2
87
497
JN4AD
NOMESCO Finland
Body CT examination
2.6
7.1
44
187
137
Kela drug reimbursment
Uraemia requiring dialysis
14.3
7.0
11
8
J01MA12
ATC
levofloxacin; systemic
2.3
6.9
60
298
JN3AA
NOMESCO Finland
Abdominal X-ray examination without contrast
4.3
6.9
18
44
RD210, ,
NOMESCO Finland
9.7
6.9
13
14
Z49.2
ICD-10 Finland
Other dialysis
17.3
6.8
10
6
XX6KT
NOMESCO Finland
Other sclerotherapy
41.2
6.8
8
*
JN1BD
NOMESCO Finland
Extensive CT examination of upper part of abdomen
23.2
6.7
9
*
GD1UA
NOMESCO Finland
Thorax X-ray examination outside radiological department
2.4
6.5
51
242
Z94.9
ICD-10 Finland
Transplanted organ and tissue status, unspecified
71.6
6.5
7
*
JL5BG
NOMESCO Finland
MRI examinaiton of bile and pancreas ducts with high intesity magnet
6.2
6.4
16
27
N39.0
ICD-10 Finland
Urinary tract infection, site not specified
2.3
6.4
54
265
B03XA01
ATC
erythropoietin; parenteral
18.6
6.3
9
5
K43.9
ICD-10 Finland
Other and unspecified ventral hernia without obstruction or gangrene
3.5
6.3
22
67
75310
ICD-8 Finland
Congenital anomalies of urinary system, Ren polycysticus bilateralis
+∞
6.3
6
*
PG5DE
NOMESCO Finland
Ultrasound examination of injection gate to artery or vein with Doppler method
27.4
6.3
8
*
A02BC05
ATC
esomeprazole; systemic
1.9
6.2
120
801
K83.0
ICD-10 Finland
Cholangitis
10.4
6.1
11
11
TimeCodeWAS
↥TODO / Current known limitations:
- Only showing the top 500 codes, because showing all (sometimes 20k) makes the page too slow.
- Legend / how to read the glyphs.
- Proper column names.
- Show details (e.g. Fisher or Chi-square test, N cases and N controls) when clicking on a row.
- Explanation on the underlying data / how the TimeCodeWAS is done (e.g. matched cases / controls, eligibility).
- Download CSV not working.
- No filters and sorters.
- Limited amount of endpoints with TimeCodeWAS data.
- Cross-links to Risteys lab test pages for lab test codes.
OMOP Concept
ln(OR) -5y
ln(OR) -1y
ln(OR) -1m
ln(OR) d0
ln(OR) +1m
ln(OR) +1y
ln(OR) +5y
MCC -5y
MCC -1y
MCC -1m
MCC d0
MCC +1m
MCC +1y
MCC +5y
Cystic disease of liver
Q44.6 (45553680)
Q44.6 (45553680)
Hepatic cyst
K76.80 (2000502934)
K76.80 (2000502934)
Sclerotherapy of liver cyst
JJ5KT (2001305263)
JJ5KT (2001305263)
Polycystic kidney, unspecified
Q61.3 (45592380)
Q61.3 (45592380)
Alpha-1-Fetoprotein [Units/volume] in Serum or Plasma
19176-7 (3015916)
19176-7 (3015916)
Body height measure
50373000 (4177340)
50373000 (4177340)
Body mass index
60621009 (4245997)
60621009 (4245997)
Thorax X-ray examination
GD1AA (2001303617)
GD1AA (2001303617)
Ultrasound examination of upper part of abdomen
JN1AE (2001305517)
JN1AE (2001305517)
Abdominal ultrasound examination
JN3AE (2001305555)
JN3AE (2001305555)
SMOKING - SMOKE2: no - SMOKE3: never - SMOKE5: Unspecified
SMOKING-2-3-0 (2002330113)
SMOKING-2-3-0 (2002330113)
Bilirubin.conjugated [Moles/volume] in Serum or Plasma
29760-6 (3005772)
29760-6 (3005772)
Prealbumin [Mass/volume] in Serum or Plasma
14338-8 (3013742)
14338-8 (3013742)
Amylase [Enzymatic activity/volume] in Serum or Plasma
1798-8 (3016771)
1798-8 (3016771)
Magnesium Ionized [Moles/volume] in Serum or Plasma
2600-5 (3021197)
2600-5 (3021197)
Prothrombin time (PT) actual/Normal
5894-1 (3033658)
5894-1 (3033658)
Gastroenterology
10 (38004455)
10 (38004455)
Upper gastrointestinal surgery
106 (44777669)
106 (44777669)
Polycystic kidney, autosomal dominant
Q61.2 (45558415)
Q61.2 (45558415)
Kidney transplant status
Z94.0 (45566477)
Z94.0 (45566477)
Other and unspecified abdominal pain
R10.4 (45568113)
R10.4 (45568113)
Inpatient Hospital
21 (8717)
21 (8717)
Outpatient Hospital
22 (8756)
22 (8756)
Nephrology
39 (38004479)
39 (38004479)
Urea [Moles/volume] in Serum or Plasma
22664-7 (3020779)
22664-7 (3020779)
mycophenolic acid; oral, parenteral
L04AA06 (21603896)
L04AA06 (21603896)
Albumin [Mass/volume] in Serum or Plasma
1751-7 (3024561)
1751-7 (3024561)
Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
6768-6 (3035995)
6768-6 (3035995)
Transferrin [Mass/volume] in Serum or Plasma
3034-6 (3004789)
3034-6 (3004789)
Phosphate [Moles/volume] in Serum or Plasma
14879-1 (3003458)
14879-1 (3003458)
Cystatin C [Mass/volume] in Serum or Plasma
33863-2 (3030366)
33863-2 (3030366)
Bilirubin.total [Moles/volume] in Serum or Plasma
14631-6 (3006140)
14631-6 (3006140)
Outpatient Visit
OP (9202)
OP (9202)
pH of Serum or Plasma
2753-2 (3018418)
2753-2 (3018418)
Cancer Ag 19-9 [Units/volume] in Serum or Plasma
24108-3 (3022914)
24108-3 (3022914)
Calcium.ionized [Moles/volume] in Serum or Plasma
1995-0 (3021347)
1995-0 (3021347)
Iron/Transferrin [Ratio] in Serum or Plasma
60517-0 (40763571)
60517-0 (40763571)
Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma
1920-8 (3013721)
1920-8 (3013721)
Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
19072-8 (3016431)
19072-8 (3016431)
Glucose [Moles/volume] in Serum or Plasma
14749-6 (3013826)
14749-6 (3013826)
Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
2324-2 (3026910)
2324-2 (3026910)
Iron [Moles/volume] in Serum or Plasma
14798-3 (3022948)
14798-3 (3022948)
INR in Blood by Coagulation assay
34714-6 (3032080)
34714-6 (3032080)
Parathyrin.intact [Mass/volume] in Serum or Plasma
2731-8 (3000067)
2731-8 (3000067)
Gas panel - Venous blood
24339-4 (3000991)
24339-4 (3000991)
Erythrocyte [DistWidth] in Red Blood Cells
30385-9 (3002385)
30385-9 (3002385)
General Surgery
2 (38004447)
2 (38004447)
Creatinine [Moles/volume] in Serum or Plasma
14682-9 (3020564)
14682-9 (3020564)
Internal Medicine
11 (38004456)
11 (38004456)
Supplier / Service Provider
OMOP5117446 (33004)
OMOP5117446 (33004)
Base excess in Venous blood by calculation
1927-3 (3002032)
1927-3 (3002032)
Platelets [#/volume] in Blood
26515-7 (3007461)
26515-7 (3007461)
MCV [Entitic mean volume] in Red Blood Cells
30428-7 (3024731)
30428-7 (3024731)
Erythrocytes [#/volume] in Blood
26453-1 (3026361)
26453-1 (3026361)
MCH [Entitic mass]
28539-5 (3035941)
28539-5 (3035941)
Erythrocytes [#/volume] in Urine
30391-7 (3002582)
30391-7 (3002582)
Hemoglobin [Mass/volume] in Blood
718-7 (3000963)
718-7 (3000963)
Leukocytes [#/volume] in Blood
26464-8 (3010813)
26464-8 (3010813)
Hematocrit [Volume Fraction] of Blood by calculation
20570-8 (3009542)
20570-8 (3009542)
Urinalysis microscopic panel [#/volume] - Urine by Automated count
50554-5 (3029287)
50554-5 (3029287)
CBC panel - Blood by Automated count
58410-2 (40761511)
58410-2 (40761511)
pH of Venous blood
2746-6 (3012544)
2746-6 (3012544)
Carbon dioxide [Partial pressure] in Venous blood
2021-4 (3021447)
2021-4 (3021447)
Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction
14804-9 (3022250)
14804-9 (3022250)
Pain localized to upper abdomen
R10.1 (45568111)
R10.1 (45568111)
Emergency Room Visit
ER (9203)
ER (9203)
Hepatitis C virus Ab [Presence] in Serum
16128-1 (3017143)
16128-1 (3017143)
Leukocytes [#/volume] in Urine
30405-5 (3018095)
30405-5 (3018095)
Hepatitis B virus surface Ag [Presence] in Serum
5195-3 (3019284)
5195-3 (3019284)
Blood group antibody screen [Presence] in Serum or Plasma
890-4 (3001079)
890-4 (3001079)
C reactive protein [Mass/volume] in Serum or Plasma
1988-5 (3020460)
1988-5 (3020460)
Bacteria [Presence] in Urine
87829-8 (36304419)
87829-8 (36304419)
Casts [#/volume] in Urine by Automated count
51483-6 (3030467)
51483-6 (3030467)
Laboratory Visit
OMOP4822461 (32036)
OMOP4822461 (32036)
Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
72493-0 (43055120)
72493-0 (43055120)
Case Management Agency
251B00000X (38004193)
251B00000X (38004193)
Bacteria identified in Isolate by Culture
43409-2 (3042936)
43409-2 (3042936)
Sodium [Moles/volume] in Serum or Plasma
2951-2 (3019550)
2951-2 (3019550)
Potassium [Moles/volume] in Serum or Plasma
2823-3 (3023103)
2823-3 (3023103)
MCHC [Entitic Mass/volume] in Red Blood Cells
28540-3 (3003338)
28540-3 (3003338)
Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)/1.73 sq M
62238-1 (40764999)
62238-1 (40764999)
Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
1742-6 (3006923)
1742-6 (3006923)
ANTIHYPERTENSIVE_DRUG - yes
ANTIHYPERTENSIVE_DRUG-1 (2002330215)
ANTIHYPERTENSIVE_DRUG-1 (2002330215)
LabWAS
↥
OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
cases
controls
unit
-log10(p)
N cases
N controls
49
35
17.09
55.14
2.0
2.3
3.12
108.75
u/ml
0.49
49
35
46
49
11.23
40.13
11.9
5.5
452.22
138.17
iu/ml
—
18
6
54
73
9.12
39.37
8.6
3.1
1.91
1.48
mg/l
1.79
54
63
102
277
5.47
37.24
11.7
2.8
6.00
7.41
umol/l
0.64
96
247
211
1063
6.71
35.07
16.1
4.6
35.81
35.86
g/l
0.05
203
1005
39
40
11.33
34.76
1.9
1.2
—
—
—
0
0
38
38
11.58
34.45
1.7
1.1
284.84
295.56
u/ml
0.04
32
18
106
315
5.05
34.38
21.2
5.8
1.13
1.04
mmol/l
2.04
99
289
38
40
10.99
33.23
1.9
1.1
167.57
170.60
au/ml
0.05
14
14
61
115
6.66
32.72
2.9
3.3
235.33
2108.83
u/ml
0.86
54
99
38
42
10.46
32.07
1.6
1.1
—
—
—
0
0
61
133
5.71
27.88
12.7
4.0
23.36
24.38
mmol/l
2.02
61
133
200
1090
4.87
26.63
18.7
12.4
1.18
1.20
inr
0.17
167
892
28
11
28.39
20.94
5.1
1.5
95.96
111.73
%
1.23
28
11
34
55
6.98
20.77
1.8
1.1
—
—
—
0
0
149
768
3.26
19.12
5.0
2.6
63.76
70.00
u/l
0.32
142
712
63
205
3.75
16.80
3.4
2.7
51.35
64.80
ml/min/173m2
1.22
24
87
23
10
25.11
16.75
6.0
3.0
0.57
0.60
mmol/l
—
23
10
191
1201
3.35
16.35
22.7
7.1
1.20
1.22
mmol/l
1.40
172
1032
179
1094
3.13
15.91
20.2
6.3
1.21
1.22
mmol/l
0.44
171
1002
74
282
3.29
15.32
2.9
4.5
3.73
24.83
ug/l
0.81
52
236
65
229
3.47
15.26
6.4
2.4
40.53
32.23
u/l
0.78
58
186
48
149
3.74
13.55
15.7
8.3
24.15
25.09
mmol/l
1.35
48
149
111
565
2.71
13.30
3.8
2.2
—
—
—
0
0
89
414
2.77
12.62
5.9
2.9
0.43
1.01
e6/l
2.66
59
213
115
616
2.58
12.18
6.5
2.9
349.16
336.79
umol/l
0.64
107
539
49
165
3.44
12.18
1.9
1.5
—
—
—
0
0
74
319
2.86
12.05
14.7
6.6
104.11
104.05
mmol/l
0.03
74
319
22
21
11.35
12.02
1.2
1.3
—
—
—
0
0
22
21
11.35
12.02
1.2
1.2
—
—
—
0
0
111
588
2.57
12.00
3.1
2.3
2.47
3.07
mg/l
2.33
95
507
167
1075
2.60
11.86
4.6
2.7
—
—
estimate
—
0
0
168
1102
2.54
11.18
4.3
2.5
81.88
79.16
nmol/l
0.73
159
987
210
1539
3.07
11.12
10.9
3.3
83.62
46.79
u/l
3.85
202
1448
26
62
4.56
10.37
2.4
1.5
—
—
—
0
0
14
6
24.56
10.35
1.1
1.2
—
—
—
0
0
117
670
2.38
10.30
8.9
3.2
0.13
0.40
e6/l
2.65
95
474
59
246
2.82
10.07
4.1
3.5
—
—
—
0
0
78
382
2.50
9.61
6.0
3.0
1.15
2.97
e6/l
2.04
48
184
181
1278
2.43
9.50
7.5
4.0
0.00
0.00
estimate
-0.00
42
275
22
49
4.82
9.50
10.5
2.7
83.59
57.87
%
8.68
22
49
181
1289
2.39
9.15
7.5
4.0
0.00
5.72
estimate
0.50
40
284
186
1342
2.43
9.10
15.3
9.9
4.18
3.97
e9/l
0.54
167
1163
182
1301
2.39
9.09
7.6
4.1
0.00
0.00
estimate
-0.00
42
261
76
377
2.45
9.04
2.6
1.8
—
—
—
0
0
160
1093
2.25
8.77
6.4
3.1
139.07
112.17
ug/l
1.29
152
1016
61
282
2.53
8.38
2.8
1.7
—
—
—
0
0
57
271
2.42
7.31
2.9
1.8
—
—
—
0
0
54
252
2.45
7.20
13.6
7.3
-0.11
1.00
mmol/l
2.10
48
220
80
445
2.16
7.06
3.7
3.9
465.38
211.93
ng/l
0.40
69
345
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
20
53
4.01
6.95
3.9
2.9
0.31
0.33
iu/ml
—
9
28
26
84
3.33
6.81
2.0
3.8
1.32
2.18
ratio
0.65
11
46
27
92
3.16
6.49
2.1
4.2
1740.91
105.18
mg/l
0.47
21
82
27
92
3.16
6.49
2.1
4.2
49.55
31.05
mg/l
0.85
21
82
126
867
1.90
5.88
5.1
3.5
2.34
2.36
mmol/l
0.91
119
787
246
2222
4.03
5.86
42.1
15.6
22.65
22.54
mg/l
0.02
229
1806
17
36
4.98
5.73
1.5
1.4
—
—
—
0
0
9
8
11.60
5.33
1.2
1.0
1712.22
1253.25
miu/ml
—
9
8
20
64
3.31
5.32
3.6
2.9
2.69
1.55
index
0.36
13
33
119
827
1.82
5.20
6.5
4.0
5.87
8.75
mg/mmol
0.81
94
481
211
1759
2.16
5.19
6.6
4.6
15.12
12.38
mm/h
1.76
201
1636
22
76
3.07
5.18
4.0
1.2
0.89
0.90
g/l
0.05
22
76
31
133
2.52
4.89
10.4
2.7
1.25
1.22
%
0.05
31
133
143
1065
1.78
4.84
2.5
2.1
94.03
97.58
pmol/l
0.48
82
529
26
103
2.70
4.80
2.1
1.4
0.21
0.30
mg/l
—
8
40
107
735
1.79
4.75
2.0
1.7
20.34
21.74
nmol/l
0.48
95
616
30
129
2.50
4.72
3.0
1.7
—
—
—
0
0
17
54
3.30
4.57
8.9
2.5
11.15
9.17
pmol/l
0.22
17
54
30
132
2.44
4.50
10.6
2.7
0.71
0.60
%
0.53
30
132
117
839
1.73
4.38
6.0
3.2
6.75
7.41
mmol/l
0.98
107
687
85
557
1.79
4.36
6.5
4.0
1.02
1.02
kg/l
0.63
64
360
103
732
1.68
3.87
8.0
4.1
0.00
0.00
estimate
-0.00
39
262
61
385
1.77
3.47
1.9
1.7
1129.19
1204.57
nmol/l
0.33
51
284
126
973
1.58
3.24
7.2
3.9
0.00
0.01
estimate
0.80
37
230
7
11
6.51
3.20
2.0
2.0
134.79
63.75
ug/l
—
7
11
9
20
4.62
3.14
1.2
3.0
3.69
3.08
nmol/l
—
9
20
75
524
1.61
2.88
3.7
2.6
2.45
2.45
mmol/l
0.12
70
473
17
71
2.49
2.87
1.4
1.2
—
—
—
0
0
237
2184
2.21
2.77
36.5
15.6
69.22
79.75
ml/min/173m2
7.94
231
2030
6
10
6.11
2.71
1.5
2.6
3.83
4.29
ug/l
—
6
10
158
1317
1.52
2.68
3.3
2.9
—
—
—
0
0
133
1072
1.50
2.63
2.6
2.0
1.10
1.33
mmol/l
5.92
112
895
6
11
5.56
2.56
3.8
2.9
1.00
0.64
index
—
6
11
22
111
2.07
2.44
5.3
3.1
0.41
1.99
mmol/l
1.40
11
85
6
12
5.09
2.41
2.7
2.1
—
—
—
0
0
96
734
1.49
2.41
1.9
2.1
132.21
178.86
u/l
0.71
91
693
22
118
1.95
2.09
1.7
1.3
—
—
—
0
0
17
84
2.10
2.01
2.1
2.0
145.59
314.23
ug/l
1.26
17
79
9
34
2.71
1.88
1.1
1.1
—
—
—
0
0
6
17
3.59
1.85
5.3
2.9
814.67
595.30
ml
—
6
10
71
536
1.45
1.84
2.4
1.8
1.79
1.28
mg/l
0.82
55
435
5
12
4.23
1.83
1.2
1.4
—
—
—
0
0
9
35
2.63
1.82
2.2
1.3
—
—
—
0
0
7
23
3.10
1.81
1.0
1.5
—
—
—
0
0
11
47
2.40
1.80
6.9
3.0
4.94
5.07
kpa
0.30
11
47
14
67
2.15
1.79
1.5
1.3
105.40
300.58
miu/ml
—
5
31
12
54
2.28
1.77
1.5
1.3
—
—
—
0
0
6
18
3.39
1.75
1.3
1.1
—
—
—
0
0
6
18
3.39
1.75
1.3
1.1
—
—
—
0
0
234
2202
1.76
1.72
7.1
5.4
5.72
5.96
mmol/l
2.65
220
2044
93
746
1.39
1.70
2.3
3.2
1847.26
1134.07
ng/l
0.72
87
633
15
76
2.03
1.68
1.7
1.8
—
—
—
0
0
6
19
3.21
1.67
4.7
2.6
15.00
13.82
index
—
6
11
6
19
3.21
1.67
1.0
3.6
1188.67
1091.26
mg
—
6
19
109
903
1.36
1.62
3.2
3.8
73.99
92.13
ng/l
0.08
79
651
13
64
2.09
1.57
1.8
1.3
—
—
—
0
0
5
15
3.38
1.53
1.0
1.1
—
—
—
0
0
15
81
1.91
1.43
1.5
1.3
191.33
309.54
ug/g
—
9
47
13
67
1.99
1.41
2.6
2.0
—
—
—
0
0
11
53
2.12
1.40
1.7
1.3
—
—
—
0
0
230
2175
1.59
1.38
9.0
6.7
37.78
39.33
mmol/mol
2.73
222
2040
14
75
1.92
1.37
1.5
1.3
—
—
—
0
0
14
75
1.92
1.37
1.6
1.7
—
—
—
0
0
6
135
0.43
1.31
1.3
2.3
12.40
13.24
nmol/l
—
6
128
236
2250
1.66
1.31
7.2
5.4
4.51
4.72
mmol/l
2.78
224
2096
5
18
2.81
1.29
7.8
1.2
28.90
21.16
umol/l
—
5
10
53
405
1.39
1.27
1.5
1.5
—
—
—
0
0
238
2279
1.66
1.22
8.0
6.2
2.58
2.75
mmol/l
2.52
223
2115
0
33
0.00
1.17
0.0
1.1
—
—
—
0
0
8
39
2.08
1.16
3.1
1.3
—
—
—
0
0
8
39
2.08
1.16
3.1
1.3
—
—
—
0
0
8
41
1.98
1.09
2.4
1.4
—
—
—
0
0
84
706
1.28
1.06
5.4
3.4
0.00
0.00
estimate
-0.00
36
225
18
116
1.59
0.99
1.0
1.1
—
—
—
0
0
5
23
2.20
0.98
1.4
1.7
6.58
4.33
mg/l
—
5
23
7
36
1.97
0.98
2.4
1.4
—
—
—
0
0
9
50
1.83
0.97
1.4
1.3
—
—
—
0
0
52
414
1.32
0.97
5.1
4.6
25.28
21.35
%
0.75
26
205
0
31
0.00
0.97
0.0
1.1
—
—
—
0
0
11
62
1.81
0.95
1.4
1.7
5.20
4.48
iu/l
—
6
29
6
27
2.25
0.94
2.7
1.2
95.33
101.11
pmol/l
—
6
27
9
52
1.76
0.93
2.1
1.4
—
—
—
0
0
14
86
1.66
0.93
1.5
1.6
—
—
—
0
0
222
2118
1.37
0.92
5.8
5.8
1.94
1.92
mu/l
0.09
211
1955
8
45
1.80
0.85
2.4
1.4
—
—
—
0
0
6
31
1.96
0.85
1.2
1.3
—
—
—
0
0
11
66
1.70
0.80
2.0
1.3
—
—
—
0
0
0
26
0.00
0.79
0.0
1.0
—
—
—
0
0
194
1831
1.25
0.78
4.7
4.6
15.24
14.81
pmol/l
1.74
186
1681
6
34
1.78
0.77
2.8
1.4
—
—
—
0
0
9
58
1.57
0.70
1.2
1.1
—
3.26
—
0
8
5
29
1.74
0.64
1.2
1.1
—
—
—
0
0
0
20
0.00
0.60
0.0
1.1
—
1.18
—
0
12
231
2243
1.32
0.59
7.2
5.3
1.53
1.52
mmol/l
0.10
216
2077
33
268
1.27
0.56
16.6
7.0
—
—
—
0
0
9
60
1.52
0.55
2.1
1.4
—
—
—
0
0
44
515
0.82
0.52
1.5
1.3
12.29
37.13
iu/ml
—
10
167
27
217
1.27
0.50
1.9
2.2
3.29
3.36
ratio
0.12
18
180
7
47
1.50
0.48
2.4
1.4
—
—
—
0
0
56
493
1.17
0.45
1.6
1.8
499.98
28058009.10
pmol/l
0.50
48
417
15
113
1.35
0.43
1.5
1.6
20.80
4.75
iu/ml
—
5
28
5
31
1.62
0.43
2.2
1.4
—
—
—
0
0
25
204
1.25
0.42
1.8
1.4
—
—
—
0
0
5
32
1.57
0.42
2.4
1.4
—
—
—
0
0
5
32
1.57
0.42
2.4
1.4
—
—
—
0
0
220
2141
1.20
0.42
5.9
4.5
1.12
1.27
mmol/l
4.98
203
1971
22
177
1.27
0.42
1.4
1.2
56.42
150.96
u/ml
—
9
69
0
15
0.00
0.41
0.0
1.8
—
—
—
0
0
0
18
0.00
0.40
0.0
1.1
—
—
—
0
0
0
18
0.00
0.40
0.0
1.0
—
—
—
0
0
12
90
1.35
0.36
1.9
1.5
—
—
—
0
0
64
580
1.14
0.36
1.4
1.2
4.72
1.46
u/ml
0.44
12
169
36
318
1.15
0.29
4.0
3.2
0.96
0.78
ug/l
0.52
26
206
11
85
1.31
0.28
1.3
1.1
—
—
—
0
0
19
159
1.21
0.27
1.7
2.0
3.54
3.48
mmol/l
—
10
120
8
66
1.22
0.27
1.1
1.3
—
1.04
—
0
5
11
86
1.29
0.26
1.3
1.1
—
—
—
0
0
5
72
0.69
0.26
1.0
1.2
1.64
1.58
g/l
—
5
72
5
38
1.32
0.23
2.2
1.2
—
—
nmol/l
—
0
0
0
11
0.00
0.21
0.0
1.1
—
—
—
0
0
0
10
0.00
0.21
0.0
1.2
—
—
—
0
0
0
10
0.00
0.21
0.0
1.1
—
—
—
0
0
0
10
0.00
0.21
0.0
1.0
—
—
—
0
0
0
10
0.00
0.21
0.0
1.0
—
—
—
0
0
0
10
0.00
0.21
0.0
1.1
—
—
—
0
0
0
12
0.00
0.21
0.0
1.3
—
9.83
—
0
12
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
0
12
0.00
0.21
0.0
1.2
—
—
—
0
0
0
12
0.00
0.21
0.0
1.3
—
—
—
0
0
0
13
0.00
0.21
0.0
1.6
—
—
—
0
0
0
13
0.00
0.21
0.0
1.0
—
—
—
0
0
0
14
0.00
0.20
0.0
1.4
—
1.22
—
0
8
14
119
1.19
0.18
1.3
1.3
35.04
27.62
iu/l
0.24
14
97
8
71
1.13
0.16
1.1
1.2
—
—
—
0
0
9
82
1.10
0.15
1.9
1.6
—
—
—
0
0
44
469
0.93
0.14
1.5
1.3
1.52
13.64
u/ml
3.15
20
186
37
393
0.93
0.11
1.8
1.6
—
—
—
0
0
17
153
1.12
0.11
1.4
1.4
—
28.31
—
0
14
8
93
0.86
0.07
2.1
1.7
—
—
—
0
0
16
172
0.93
0.06
1.8
1.8
—
—
—
0
0
14
130
1.08
0.04
1.6
1.3
—
—
—
0
0
18
188
0.95
0.02
1.7
1.9
—
—
—
0
0
0
7
0.00
-0.00
0.0
1.1
—
—
—
0
0
0
7
0.00
-0.00
0.0
1.7
—
60.31
—
0
7
0
7
0.00
-0.00
0.0
1.3
—
—
—
0
0
0
8
0.00
-0.00
0.0
1.1
—
—
—
0
0
8
84
0.95
-0.00
1.3
1.3
—
1.58
—
0
5
5
59
0.84
-0.00
1.2
1.5
224.60
310.71
mu/l
—
5
52
0
8
0.00
-0.00
0.0
1.1
—
—
—
0
0
0
7
0.00
-0.00
0.0
1.1
—
—
—
0
0
8
81
0.99
-0.00
1.3
1.3
—
3.04
—
0
14
7
76
0.92
-0.00
2.1
2.9
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.0
—
—
—
0
0
5
58
0.86
-0.00
1.4
1.7
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
7
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
8
0.00
-0.00
0.0
1.1
—
—
—
0
0
0
6
0.00
-0.00
0.0
10.5
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.0
—
0.26
—
0
5
0
5
0.00
-0.00
0.0
1.2
—
—
—
0
0
7
69
1.01
-0.00
1.7
1.7
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.3
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.2
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.3
—
—
—
0
0
0
7
0.00
-0.00
0.0
1.1
—
—
—
0
0
0
8
0.00
-0.00
0.0
1.1
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.0
—
—
—
0
0
Mortality – FinRegistry
↥This endpoint is excluded (different definition than used in FinnGen).
Relationships between endpoints
↥Index endpoint: Q17_CYSTIC_DISEASE_OF_LIVER – Cystic disease of liver
GWS hits: 12
This endpoint is excluded (different definition than used in FinnGen).